Salarius Pharmaceuticals
SLRX
SLRX
27 hedge funds and large institutions have $859K invested in Salarius Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
KC
1
Kepos Capital
New York
|
$0 |
| 2 |
SRC
2
Shufro Rose & Co
New York
|
$0 |
| 3 |
3
Two Sigma Advisers
New York
|
$69K |
| 4 |
4
Jane Street
New York
|
$0 |
| 5 |
XSC
5
X-Square Capital
Guaynabo,
Puerto Rico
|
$19K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SRC
26
Shufro Rose & Co
New York
| – | – | -16,400 | Closed |
|
|
27
Jane Street
New York
| – | – | -11,068 | Closed |
|
28
JPMorgan Chase & Co
New York
| – | – | -2,857 | Closed |
|
|
SMG
29
Spectrum Management Group
Indianapolis,
Indiana
| – | – | -595 | Closed |
|
30
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $0 | 1,000 | – | – |
|
|
CFGS
31
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
32
Morgan Stanley
New York
| $0 | 1,500 | – | – |
|
33
Wells Fargo
San Francisco,
California
| $0 | 375 | +97 | +35% |
|